Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 25, 2016 - Issue 9
Submit an article Journal homepage
568
Views
19
CrossRef citations to date
0
Altmetric
Drug Evaluation

Panobinostat for the treatment of acute myelogenous leukemia

Fortunato MorabitoHematology Unit, Department of Onco-Hematology, A.O. of Cosenza, Cosenza, Italy;Biotechnology Research Unit, ASP of Cosenza, Aprigliano (CS), ItalyCorrespondence[email protected]
View further author information
,
Maria Teresa VosoDepartment of Biomedicine and Prevention, Universita’ Tor Vergata, Rome, ItalyView further author information
,
Stefan HohausDepartment of Hematology, Universita’ Cattolica S. Cuore, Rome, ItalyView further author information
,
Massimo GentileHematology Unit, Department of Onco-Hematology, A.O. of Cosenza, Cosenza, ItalyView further author information
,
Ernesto VignaHematology Unit, Department of Onco-Hematology, A.O. of Cosenza, Cosenza, ItalyView further author information
,
Anna Grazia RecchiaBiotechnology Research Unit, ASP of Cosenza, Aprigliano (CS), ItalyView further author information
,
Lorenzo IovinoDepartment of Clinical and Experimental Medicine, Hematology Division, University of Pisa, Pisa, ItalyView further author information
,
Edoardo BenedettiDepartment of Clinical and Experimental Medicine, Hematology Division, University of Pisa, Pisa, ItalyView further author information
,
Francesco Lo-CocoDepartment of Biomedicine and Prevention, Universita’ Tor Vergata, Rome, ItalyView further author information
&
Sara GalimbertiDepartment of Clinical and Experimental Medicine, Hematology Division, University of Pisa, Pisa, ItalyView further author information
 show all
Pages 1117-1131 | Received 15 Feb 2016, Accepted 21 Jul 2016, Published online: 08 Aug 2016

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Laura C. Michaelis, Heidi D. Klepin & Roland B. Walter. (2018) Advancements in the management of medically less-fit and older adults with newly diagnosed acute myeloid leukemia. Expert Opinion on Pharmacotherapy 19:8, pages 865-882.
Read now

Articles from other publishers (18)

Yu Wang & Hidekatsu Iha. (2023) The Novel Link between Gene Expression Profiles of Adult T-Cell Leukemia/Lymphoma Patients’ Peripheral Blood Lymphocytes and Ferroptosis Susceptibility. Genes 14:11, pages 2005.
Crossref
Danielle Shafer, Amanda B. Kagan, Michelle A. Rudek, Maciej Kmieciak, Mary Beth Tombes, Ellen Shrader, Dipankar Bandyopadhyay, Daniel Hudson, Heidi Sankala, Caryn Weir, Jeffrey E. Lancet & Steven Grant. (2023) Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies. Cancer Chemotherapy and Pharmacology 91:3, pages 281-290.
Crossref
Showkeen Muzamil Bashir, Gulzar Ahmed Rather, Ana Patrício, Zulfiqar Haq, Amir Amin Sheikh, Mohd Zahoor ul Haq Shah, Hemant Singh, Azmat Alam Khan, Sofi Imtiyaz, Sheikh Bilal Ahmad, Showket Nabi, Rabia Rakhshan, Saqib Hassan & Pedro Fonte. (2022) Chitosan Nanoparticles: A Versatile Platform for Biomedical Applications. Materials 15:19, pages 6521.
Crossref
Jingru Yang, Cong Song & Xianquan Zhan. (2022) The role of protein acetylation in carcinogenesis and targeted drug discovery. Frontiers in Endocrinology 13.
Crossref
Mahdieh Mehrpouri, Atieh Pourbagheri-Sigaroodi & Davood Bashash. (2021) The contributory roles of histone deacetylases (HDACs) in hematopoiesis regulation and possibilities for pharmacologic interventions in hematologic malignancies. International Immunopharmacology 100, pages 108114.
Crossref
Marcos de Lima, Gail J. Roboz, Uwe Platzbecker, Charles Craddock & Gert Ossenkoppele. (2021) AML and the art of remission maintenance. Blood Reviews 49, pages 100829.
Crossref
Øystein Bruserud, Galina Tsykunova, Maria Hernandez-Valladares, Hakon Reikvam & Tor Henrik Anderson Tvedt. (2021) Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation. Pharmaceuticals 14:5, pages 423.
Crossref
Lynne W. Elmore, Susanna F. Greer, Elvan C. Daniels, Charles C. Saxe, Michael H. Melner, Ginger M. Krawiec, William G. Cance & William C. Phelps. (2020) Blueprint for cancer research: Critical gaps and opportunities. CA: A Cancer Journal for Clinicians 71:2, pages 107-139.
Crossref
Bowen Yan, David Claxton, Suming Huang & Yi Qiu. (2020) AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy. Experimental Hematology 87, pages 13-19.
Crossref
Xu Hu, Yan Wang, Xiang Gao, Shengtao Xu, Linghe Zang, Yan Xiao, Zhanlin Li, Huiming Hua, Jinyi Xu & Dahong Li. (2020) Recent Progress of Oridonin and Its Derivatives for the Treatment of Acute Myelogenous Leukemia. Mini-Reviews in Medicinal Chemistry 20:6, pages 483-497.
Crossref
Mark P. Waterhouse, Rosie Ugur & Walid T. Khaled. (2019) Therapeutic and Mechanistic Perspectives of Protein Complexes in Breast Cancer. Frontiers in Cell and Developmental Biology 7.
Crossref
Anita M.A.P. Govers, Caroline R.M. Wiggers, Ruben van Boxtel, Michal Mokry, Edward E.S. Nieuwenhuis, Menno P. Creyghton, Marije Bartels & Paul J. Coffer. (2019) Transcriptomic and Epigenomic Profiling of Histone Deacetylase Inhibitor Treatment Reveals Distinct Gene Regulation Profiles Leading to Impaired Neutrophil Development. HemaSphere 3:4, pages e270.
Crossref
Lambert, Alioui, Jambon, Depauw, Van Seuningen & David-Cordonnier. (2019) Direct and Indirect Targeting of HOXA9 Transcription Factor in Acute Myeloid Leukemia.. Cancers 11:6, pages 837.
Crossref
Beatrice U. Mueller, Katja Seipel & Thomas Pabst. (2018) Myelodysplastic syndromes and acute myeloid leukemias in the elderly. European Journal of Internal Medicine 58, pages 28-32.
Crossref
Johanna Ungerstedt. (2018) Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors. International Journal of Molecular Sciences 19:10, pages 3091.
Crossref
Mélanie Lambert, Samy Jambon, Sabine Depauw & Marie-Hélène David-Cordonnier. (2018) Targeting Transcription Factors for Cancer Treatment. Molecules 23:6, pages 1479.
Crossref
Qing Zhang, Yifan Dai, Zhiming Cai & Lisha Mou. (2018) HDAC Inhibitors: Novel Immunosuppressants for Allo- and Xeno- Transplantation. ChemistrySelect 3:1, pages 176-187.
Crossref
Utz Krug, Robert Peter Gale, Wolfgang E. Berdel, Carsten Müller-Tidow, Matthias Stelljes, Klaus Metzeler, M. Cristina Sauerland, Wolfgang Hiddemann & Thomas Büchner. (2017) Therapy of older persons with acute myeloid leukaemia. Leukemia Research 60, pages 1-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.